Immuron (IMRN) Operating Interest Expenses (2016 - 2024)
Immuron (IMRN) posted Operating Interest Expenses of $2133.5 for Q3 2024, down 96.93% on a QoQ basis from $69441.8 in Q4 2023.
Analysis
Immuron (IMRN) Operating Interest Expenses (2016 - 2024) Analysis & Trends
Immuron has reported Operating Interest Expenses for 9 years, with the latest figure at $2133.5 in Q3 2024.
- On a quarterly basis, Operating Interest Expenses changed N/A year-over-year to $2133.5 in Q3 2024; TTM through Sep 2024 was $73027.8, a N/A change from a year earlier, with the FY2025 full-year figure at $83324.2, down 60.32% from the prior year.
- Operating Interest Expenses was $2133.5 for Q3 2024 at Immuron, down from $69441.8 in the prior quarter.
- The five-year high for Operating Interest Expenses was $69441.8 in Q4 2023, with the low at -$14177.4 in Q2 2020.
- Average Operating Interest Expenses over 5 years is $6924.5, with a median of $195.94 recorded in 2021.
- The sharpest annual moves came in 2020 and 2023: Operating Interest Expenses jumped 43.58% in 2020, then soared 21221.29% in 2023.
- Over 5 years, Operating Interest Expenses stood at -$11.78 in 2020, then soared by 662.1% to $66.19 in 2021, then surged by 392.06% to $325.69 in 2022, then soared by 21221.29% to $69441.8 in 2023, then slumped by 96.93% to $2133.5 in 2024.
- The last three Operating Interest Expenses figures came in at $2133.5 (Q3 2024), $69441.8 (Q4 2023), and $1126.9 (Q2 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Interest Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Immuron | 10.28 Mn | 1.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 9, 2024 | 2,133.47 |
| Dec 31, 2023 | 69,441.81 |
| Jun 30, 2023 | 1,126.86 |
| Dec 31, 2022 | 325.69 |
| Dec 31, 2021 | 66.19 |
| Jun 30, 2021 | -3,509.14 |
| Dec 31, 2020 | -11.78 |
| Jun 30, 2020 | -14,177.40 |
| Dec 31, 2019 | -20.87 |
| Dec 31, 2018 | -39.00 |
| Dec 31, 2017 | -2,896.97 |
| Dec 31, 2016 | -9,939.69 |
| Jun 30, 2016 | -255,073.54 |